Abstract
The title compounds, 3,3′,3″,3′′′-[methylenebis(oxybenzene-5,1,3-triyl)]tetrakis(6,8-diaryl[1,2,4]triazolo[3,4-b][1,3,4]thiadiazepines), were synthesized starting from dimethyl 4-hydroxyisophthalate which was reacted with dibromomethane to obtain tetramethyl 5,5′-[methylenebis(oxy)]di(benzene-1,3-dicarboxylate). The latter was treated with excess hydrazine hydrate, and the resulting tetrahydrazide was converted to tetrakis-1,2,4-triazolyl derivative via cyclization with ethanolic potassium hydroxide, carbon disulfide, and hydrazine hydrate. In the final stage, cyclocondensation with substituted chalcones afforded the target products. The structure of the newly synthesized compounds was confirmed by elemental analyses and FT-IR and NMR spectra, and their antimicrobial activities against some bacterial and fungal strains were estimated by the disc diffusion method.
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.